Biomarin Pharmaceutical Inc
BMRN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001048477
In the last 90 days, Biomarin Pharmaceutical Inc insiders filed 0 open-market purchases and 1 sale; 565 institutions reported holding it in 13F filings for Q2 2026, worth $11.1B in total; Viking Global Investors is the only superinvestor holding it.
Holders of 5% or more of BMRN
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Biomarin Pharmaceutical Inc, largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| BlackRock, Inc. | 13G/A | 9.10%17.6M shares | −1.70 ppfrom 10.80% | Apr 29, 20252 filings | Jan 21, 2026 | SEC |
| Primecap Management Co | 13G/A | 8.24%15.8M shares | – | Aug 14, 20251 filing | Aug 14, 2025 | SEC |
| Vanguard Capital Management LLC | 13G | 5.25%10.1M shares | New | Apr 29, 20261 filing | Apr 29, 2026 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
9 Schedule 13D and 13G filings on Biomarin Pharmaceutical Inc, newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Apr 29, 20265:07 PM ET | Vanguard Capital Management LLC | 13G | 5.25%10.1M shares | New | Mar 31, 2026 | SEC |
| Mar 26, 20264:09 PM ET | Vanguard Group Inc | 13G/A | 0.00%0 shares | –Below 5% | Mar 13, 2026 | SEC |
| Jan 21, 202612:30 PM ET | BlackRock, Inc. | 13G/A | 9.10%17.6M shares | −1.70 ppfrom 10.80% | Dec 31, 2025 | SEC |
| Nov 14, 20254:53 PM ET | Viking Global Investors LPand 12 othersSuperinvestorViking Global Investors | 13G/A | 4.30%8.32M shares | −2.10 ppfrom 6.40%Below 5% | Sep 30, 2025 | SEC |
| Aug 14, 20255:32 PM ET | Viking Global Investors LPand 12 othersSuperinvestorViking Global Investors | 13G/A | 6.40%12.3M shares | – | Jun 30, 2025 | SEC |
| Aug 14, 202512:43 PM ET | Primecap Management Co | 13G/A | 8.24%15.8M shares | – | Jun 30, 2025 | SEC |
| May 13, 202511:32 AM ET | Capital Research Global Investors | 13G/A | 4.80%9.15M shares | −2.00 ppfrom 6.80%Below 5% | Mar 31, 2025 | SEC |
| Apr 29, 20259:14 AM ET | BlackRock, Inc. | 13G/A | 10.80%20.6M shares | – | Mar 31, 2025 | SEC |
| Feb 13, 20252:14 PM ET | Capital Research Global Investors | 13G/A | 6.80%13.0M shares | – | Dec 31, 2024 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Biomarin Pharmaceutical Inc shares.
No Form 144 notices for Biomarin Pharmaceutical Inc are on file.